Cover Image

Deubiquitinating enzymes for targeted cancer therapy

Saved in:

Bibliographic Details
Main Authors:	Yue Li (Author), Xiaohui Wang (Author)
Format:	Book
Published:	Wiley, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Deubiquitinating Enzymes and Bone Remodeling
by: Yu-chen Guo, et al.
Published: (2018)

Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
by: Yi-Zheng Fang, et al.
Published: (2023)

Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code
by: Yanfeng Wang, et al.
Published: (2021)

Regulation of Protein Degradation and Homeostasis by the Cytokine- Inducible Deubiquitinating Enzymes
by: Kwang-Hyun Baek
Published: (2018)

Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis
by: Can Cheng, et al.
Published: (2024)

Characterisation of the Trichinella spiralis deubiquitinating enzyme, TsUCH37, an evolutionarily conserved proteasome interaction partner.
by: Rhiannon R White, et al.
Published: (2011)

The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway
by: Minxuan Xu, et al.
Published: (2023)

The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming
by: Bharathi Suresh, et al.
Published: (2016)

Deubiquitination of Abelson tyrosine kinase: A novel regulatory mechanism targeting non‐small cell lung cancer glycolysis
by: Tong Yu, et al.
Published: (2024)

OTUD3 suppresses the mTORC1 signaling by deubiquitinating KPTN
by: Jiatao Li, et al.
Published: (2024)

Salvianolic acid B ameliorates myocardial fibrosis in diabetic cardiomyopathy by deubiquitinating Smad7
by: Hong Luo, et al.
Published: (2023)

Demethyleneberberine Alleviates Pulmonary Fibrosis through Disruption of USP11 Deubiquitinating GREM1
by: Chuang Ge, et al.
Published: (2024)

BAP1 Downregulates NRF2 Target Genes and Exerts Anti-Tumorigenic Effects by Deubiquitinating KEAP1 in Lung Adenocarcinoma
by: Jong-Su Kang, et al.
Published: (2022)

Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination
by: Qiu C, et al.
Published: (2020)

USP47-Mediated Deubiquitination and Stabilization of TCEA3 Attenuates Pyroptosis and Apoptosis of Colorectal Cancer Cells Induced by Chemotherapeutic Doxorubicin
by: Xiaodan Hou, et al.
Published: (2021)

Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
by: Yang Liu, et al.
Published: (2020)

USP15 regulates radiation-induced DNA damage and intestinal injury through K48-linked deubiquitination and stabilisation of ATM
by: Ruiqiu Zhu, et al.
Published: (2024)

LncRNA PVT1 promotes tumorigenesis of glioblastoma by recruiting COPS5 to deubiquitinate and stabilize TRIM24
by: Tao Lv, et al.
Published: (2022)

Neutrophil Extracellular Traps Induce Alveolar Macrophage Pyroptosis by Regulating NLRP3 Deubiquitination, Aggravating the Development of Septic Lung Injury
by: Cui Y, et al.
Published: (2023)

Amino Acid Degrading Enzymes and Autophagy in Cancer Therapy
by: Ziyu Wang, et al.
Published: (2021)

Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
by: Bluth MH, et al.
Published: (2011)

Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity
by: Huan-yu Guan, et al.
Published: (2017)

Targeted Thrombolytic Enzymes Delivery
by: Taimoor Hassan
Published: (2024)

Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets
by: Carla S. S. Teixeira, et al.
Published: (2021)

Targeting the untargetable KRAS in cancer therapy
by: Pingyu Liu, et al.
Published: (2019)

The Application of Inorganic Nanoparticles in Molecular Targeted Cancer Therapy: EGFR Targeting
by: Meng Sun, et al.
Published: (2021)

Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy
by: Xuejia Kang, et al.
Published: (2023)

Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets
Published: (2020)

Unmasking the Warburg Effect: Unleashing the Power of Enzyme Inhibitors for Cancer Therapy
by: Eduardo Angulo-Elizari, et al.
Published: (2023)

An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy
by: Song Yi Lee, et al.
Published: (2018)

Functional Nanomedicines for Targeted Therapy of Bladder Cancer
by: Chao Tang, et al.
Published: (2021)

Characterizing drug-metabolizing enzymes and transporters that are bona fide CAR-target genes in mouse intestine
by: Shinhee Park, et al.
Published: (2016)

Targeting Engineered Nanoparticles for Breast Cancer Therapy
by: Kumar Ganesan, et al.
Published: (2021)

Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination
by: Saiyang Xie, et al.
Published: (2022)

Macrophages as potential targets in gene therapy for cancer treatment
by: Yuanzheng Huang, et al.
Published: (2023)

Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer's Diseases Pathways
by: Thi Hanh Nguyen, et al.
Published: (2023)

From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
by: Yumeng Zhu, et al.
Published: (2022)

Clinical features and enzyme replacement therapy in 10 children with Fabry disease
by: Qian Li, et al.
Published: (2023)

Mitochondria-Targeting Chemodynamic Therapy Nanodrugs for Cancer Treatment
by: Qiaohui Chen, et al.
Published: (2022)

The effects of estrogen on targeted cancer therapy drugs
by: Ying Zhao, et al.
Published: (2022)